Gold compound kills antibiotic-resistant bacteria by attacking their defense system

Researchers have developed a gold-based drug that disables a critical survival mechanism in bacteria, making them vulnerable to conventional antibiotics. The discovery could help address the mounting crisis of antibiotic resistance, a problem that costs healthcare systems billions annually and threatens treatment options for common infections.

Originaltitel: Novel gold(III)-dithiocarbamate complex targeting bacterial thioredoxin reductase: antimicrobial activity, synergy, toxicity, and mechanistic insights